Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pressure Biosciences (PBIO)
OTHER OTC:PBIO
Holding PBIO?
Track your performance easily
PBIO Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $0.38
Previous CloseN/A
Volume28.50K
Average Volume (3M)6.00K
Market Cap
$149.52K
Enterprise ValueN/A
Total Cash (Recent Filing)$138.36K
Total Debt (Recent Filing)$655.26K
Price to Earnings (P/E)―
Beta-7.34
Next Earnings
May 15, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.38
Shares Outstanding37,379,295
10 Day Avg. Volume270
30 Day Avg. Volume6,001
Standard Deviation0.45
R-Squared0.00004
Alpha-0.00320
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.09
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Pressure Biosciences News
Ownership Overview
0.97% Insiders
―
Mutual Funds
0.02% Other Institutional Investors
99.01% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
PBIO FAQ
What was Pressure Biosciences’s price range in the past 12 months?
Pressure Biosciences lowest stock price was <$0.01 and its highest was $0.38 in the past 12 months.
What is Pressure Biosciences’s market cap?
Pressure Biosciences’s market cap is $149.52K.
When is Pressure Biosciences’s upcoming earnings report date?
Pressure Biosciences’s upcoming earnings report date is May 15, 2025 which is in 104 days.
How were Pressure Biosciences’s earnings last quarter?
Currently, no data Available
Is Pressure Biosciences overvalued?
According to Wall Street analysts Pressure Biosciences’s price is currently Overvalued.
Does Pressure Biosciences pay dividends?
Pressure Biosciences does not currently pay dividends.
What is Pressure Biosciences’s EPS estimate?
Pressure Biosciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pressure Biosciences have?
Pressure Biosciences has 37,379,295 shares outstanding.
What happened to Pressure Biosciences’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Pressure Biosciences?
Currently, no hedge funds are holding shares in PBIO
---
Company Description
Pressure Biosciences
Pressure BioSciences, Inc. is engagedin the development, marketing, and sale of proprietary laboratory instrumentation and associated consumables. Its products includes high pressure barocyclers and barozyme, high pressure generators and accessories, mini ultra-high pressure pump, barocycler and barozyme accessories, microtube accessories for barocyclers and barozyme, high pressure cell disruptors from constant systems, reagent kits, and service contracts. The firm offers its products under the brands Barocycler, PULSE, BioSeq, ProteoSolve, ProteoSolveLRS, Power of PCT, PCT Shredder, HUB440, HUB880, micro- Pestle, PCT-HD, BaroFold, Barozyme and BaroFlex, Strips,The company was founded by Richard T. Schumacher in August 1978 and is headquartered in South Easton, MA.
---
---